Folic acid-containing compound biosynthetic process

pathway activity — cross-omics
GO:0009396Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Folic acid-containing compound biosynthetic process pathway is significantly associated with the RNA expression of multiple genes, with the UCEC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are FANCI, RNU1-2, and SARS2, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Folic acid-containing compound biosynthetic process activity versus FANCI in UCEC (Pearson r = 0.24).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECFANCI →+0.545+0.180.004.00334
HNSCRNU1-2 →+1.144+0.570.005.00333
BRCASARS2 →+0.401+0.165.001<.00133
BRCATIMM50 →+0.358+0.130.004.00133
BRCASAE1 →+0.312+0.147.009<.00133
BRCATHOP1 →+0.588+0.145.001.00233
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0009396 vs FANCI — UCEC

Per-sample scatter of Folic acid-containing compound biosynthetic process activity vs FANCI in UCEC.

Explore this scatter interactively →

Exploration